66 related articles for article (PubMed ID: 23362225)
1. Conditional expression of the dominant-negative TGF-β receptor type II elicits lingual epithelial hyperplasia in transgenic mice.
Li F; Zhou M
Dev Dyn; 2013 May; 242(5):444-55. PubMed ID: 23362225
[TBL] [Abstract][Full Text] [Related]
2. The interactions of TGF-beta signalling pathway and Jagged2/Notch1 pathway induce acanthosis in lingual epithelia.
Li F; Zhou M
Pathology; 2014 Oct; 46(6):555-65. PubMed ID: 25203837
[TBL] [Abstract][Full Text] [Related]
3. Effect of conditional knockout of the type II TGF-beta receptor gene in mammary epithelia on mammary gland development and polyomavirus middle T antigen induced tumor formation and metastasis.
Forrester E; Chytil A; Bierie B; Aakre M; Gorska AE; Sharif-Afshar AR; Muller WJ; Moses HL
Cancer Res; 2005 Mar; 65(6):2296-302. PubMed ID: 15781643
[TBL] [Abstract][Full Text] [Related]
4. Dominant-negative interference of the transforming growth factor beta type II receptor in mammary gland epithelium results in alveolar hyperplasia and differentiation in virgin mice.
Gorska AE; Joseph H; Derynck R; Moses HL; Serra R
Cell Growth Differ; 1998 Mar; 9(3):229-38. PubMed ID: 9543389
[TBL] [Abstract][Full Text] [Related]
5. Transforming growth factor beta receptor type II inactivation induces the malignant transformation of intestinal neoplasms initiated by Apc mutation.
Muñoz NM; Upton M; Rojas A; Washington MK; Lin L; Chytil A; Sozmen EG; Madison BB; Pozzi A; Moon RT; Moses HL; Grady WM
Cancer Res; 2006 Oct; 66(20):9837-44. PubMed ID: 17047044
[TBL] [Abstract][Full Text] [Related]
6. Local microenvironment provides important cues for cell differentiation in lingual epithelia.
Li F; Zhou M
PLoS One; 2012; 7(4):e35362. PubMed ID: 22514735
[TBL] [Abstract][Full Text] [Related]
7. Expression of a dominant-negative mutant TGF-beta type II receptor in transgenic mice reveals essential roles for TGF-beta in regulation of growth and differentiation in the exocrine pancreas.
Böttinger EP; Jakubczak JL; Roberts IS; Mumy M; Hemmati P; Bagnall K; Merlino G; Wakefield LM
EMBO J; 1997 May; 16(10):2621-33. PubMed ID: 9184209
[TBL] [Abstract][Full Text] [Related]
8. Loss of responsiveness to transforming growth factor beta induces malignant transformation of nontumorigenic rat prostate epithelial cells.
Tang B; de Castro K; Barnes HE; Parks WT; Stewart L; Böttinger EP; Danielpour D; Wakefield LM
Cancer Res; 1999 Oct; 59(19):4834-42. PubMed ID: 10519393
[TBL] [Abstract][Full Text] [Related]
9. Differential response of epithelial stem cell populations in hair follicles to TGF-β signaling.
Lin HY; Yang LT
Dev Biol; 2013 Jan; 373(2):394-406. PubMed ID: 23103542
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor beta receptor type II inactivation promotes the establishment and progression of colon cancer.
Biswas S; Chytil A; Washington K; Romero-Gallo J; Gorska AE; Wirth PS; Gautam S; Moses HL; Grady WM
Cancer Res; 2004 Jul; 64(14):4687-92. PubMed ID: 15256431
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of transforming growth factor beta type I receptor abolishes malignant phenotype of a rat bladder carcinoma cell line.
Okamoto M; Oyasu R
Cell Growth Differ; 1997 Aug; 8(8):921-6. PubMed ID: 9269901
[TBL] [Abstract][Full Text] [Related]
12. Expression of a dominant negative type II TGF-beta receptor in mouse skin results in an increase in carcinoma incidence and an acceleration of carcinoma development.
Amendt C; Schirmacher P; Weber H; Blessing M
Oncogene; 1998 Jul; 17(1):25-34. PubMed ID: 9671311
[TBL] [Abstract][Full Text] [Related]
13. Blocking transforming growth factor beta signaling in transgenic epidermis accelerates chemical carcinogenesis: a mechanism associated with increased angiogenesis.
Go C; Li P; Wang XJ
Cancer Res; 1999 Jun; 59(12):2861-8. PubMed ID: 10383147
[TBL] [Abstract][Full Text] [Related]
14. Transforming growth factor-beta signaling helps specify tumor type in DMBA and hormone-induced mammary cancers.
Crowley MR; Frost A; Chen DT; Baffi MO; Nicola T; Serra R
Differentiation; 2006 Feb; 74(1):40-52. PubMed ID: 16466399
[TBL] [Abstract][Full Text] [Related]
15. Menin expression is regulated by transforming growth factor beta signaling in leukemia cells.
Zhang H; Liu ZG; Hua XX
Chin Med J (Engl); 2011 May; 124(10):1556-62. PubMed ID: 21740816
[TBL] [Abstract][Full Text] [Related]
16. Conditional expression of the ErbB2 oncogene elicits reversible hyperplasia in stratified epithelia and up-regulation of TGFalpha expression in transgenic mice.
Xie W; Chow LT; Paterson AJ; Chin E; Kudlow JE
Oncogene; 1999 Jun; 18(24):3593-607. PubMed ID: 10380881
[TBL] [Abstract][Full Text] [Related]
17. Absence of proximal duct apoptosis in the ventral prostate of transgenic mice carrying the C3(1)-TGF-beta type II dominant negative receptor.
Kundu SD; Kim IY; Yang T; Doglio L; Lang S; Zhang X; Buttyan R; Kim SJ; Chang J; Cai X; Wang Z; Lee C
Prostate; 2000 May; 43(2):118-24. PubMed ID: 10754527
[TBL] [Abstract][Full Text] [Related]
18. Transforming growth factor beta signaling is disabled early in human endometrial carcinogenesis concomitant with loss of growth inhibition.
Parekh TV; Gama P; Wen X; Demopoulos R; Munger JS; Carcangiu ML; Reiss M; Gold LI
Cancer Res; 2002 May; 62(10):2778-90. PubMed ID: 12019154
[TBL] [Abstract][Full Text] [Related]
19. Dissecting the role of TGF-beta type I receptor/ALK5 in pancreatic ductal adenocarcinoma: Smad activation is crucial for both the tumor suppressive and prometastatic function.
Schniewind B; Groth S; Sebens Müerköster S; Sipos B; Schäfer H; Kalthoff H; Fändrich F; Ungefroren H
Oncogene; 2007 Jul; 26(33):4850-62. PubMed ID: 17297450
[TBL] [Abstract][Full Text] [Related]
20. An emerging complexity of receptors for transforming growth factor-beta.
Derynck R; Chen RH; Ebner R; Filvaroff EH; Lawler S
Princess Takamatsu Symp; 1994; 24():264-75. PubMed ID: 8983081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
